APA (7th ed.) Citation

CC, B., SMO, T., A, L., TS, P., MLC, C., M, N., & M, Q. (2019). Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4. Clinical therapeutics, 41(10), 2008. https://doi.org/10.1016/j.clinthera.2019.07.011

Chicago Style (17th ed.) Citation

CC, Betônico, Titan SMO, Lira A, Pelaes TS, Correa-Giannella MLC, Nery M, and Queiroz M. "Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4." Clinical Therapeutics 41, no. 10 (2019): 2008. https://doi.org/10.1016/j.clinthera.2019.07.011.

MLA (9th ed.) Citation

CC, Betônico, et al. "Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4." Clinical Therapeutics, vol. 41, no. 10, 2019, p. 2008, https://doi.org/10.1016/j.clinthera.2019.07.011.